| 11.22 0 (0%) | 04-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 13.1 | 1-year : | 15.3 |
| Resists | First : | 11.22 | Second : | 13.1 |
| Pivot price | 11.18 | |||
| Supports | First : | 11.15 | Second : | 11.1 |
| MAs | MA(5) : | 11.19 |
MA(20) : | 11.18 |
| MA(100) : | 11.02 |
MA(250) : | 10.79 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 100 |
D(3) : | 77.7 |
| RSI | RSI(14): 57.5 | |||
| 52-week | High : | 11.5 | Low : | 10.28 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MACA ] has closed below upper band by 28.0%. Bollinger Bands are 18.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 11.24 - 11.29 | 11.29 - 11.34 |
| Low: | 11.09 - 11.15 | 11.15 - 11.2 |
| Close: | 11.13 - 11.23 | 11.23 - 11.3 |
Moringa Acquisition Corp does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. It focuses on pursuing opportunities in technology-based businesses or industries in Israel. The company was incorporated in 2020 and is based in New York, New York.
Fri, 01 Mar 2024
Health Tech: Week in biotech - Axios
Thu, 22 Feb 2024
Moringa to merge with biotech firm Silexion in Q3 - Investing.com
Thu, 22 Feb 2024
Silexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business ... - Yahoo Finance
Mon, 13 Jun 2022
Holisto, a Technology-Based Online Travel Booking Platform, to Become Publicly Traded Via Business Combination ... - GlobeNewswire
Fri, 13 Aug 2021
Shorting De-SPACs Could be the Play - TheStreet
Thu, 27 May 2021
Chamath's IPOE Shareholders Vote Today on SoFi Merger; Acorns and eFFECTOR Deals - TheStreet
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Shell Companies
|
|
| Shares Out | 4 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 9.1 (%) |
| Held by Institutions | 11.3 (%) |
| Shares Short | 5 (K) |
| Shares Short P.Month | 5 (K) |
| EPS | 0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.75 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -1.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 110 (M) |
| PE Ratio | 22 |
| PEG Ratio | 0 |
| Price to Book value | -15.17 |
| Price to Sales | 0 |
| Price to Cash Flow | 141.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|